Japan Cardiovascular Research Foundation   Report issue

Foundation Phase 3 Phase 4
Founded: Osaka Japan (1987)

Organization Overview

First Clinical Trial
2000
NCT00198562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Cerebral Hemorrhage (Phase 3)

Cerebral Infarction (Phase 3)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Hemorrhage (Phase 3)

Hypertension (Phase 4)

Infarction (Phase 3)

Myocardial Ischemia (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 10